Skip to main content
ARQT
NASDAQ Life Sciences

Arcutis Lifts Full-Year Sales Guidance to $535M-$545M After 45% Q3 Revenue Jump

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$29
Mkt Cap
$4.28B
52W Low
$19.295
52W High
$34.8
52W Position info
50% above low
Off High info
17% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

ARQT sits 50% above its 52-week low of $19.295.

Summary

Arcutis posted Q3 2026 revenue of $143.9 million, up 45% year over year, and raised full-year sales guidance to $535 million-$545 million. The top line is the story: ZORYVE demand is broadening across formulations after the June 2026 U.S. launch of the 0.3% cream. The blemish is profitability — EPS of $0.06 came in below estimates even as sales beat, so the quarter is a growth-over-margin print. This follows the 8-K and 10-Q filed last night showing $8.8 million of quarterly net income and $259.8 million in cash, plus the upsized $200 million at-the-market program that gives them room to keep funding the launch. Next specific item: the FDA decision on infant-use ZORYVE 0.05% is due Feb. 23, 2027.

At the time of this announcement, ARQT was trading at $29.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.3B. The 52-week trading range was $19.30 to $34.80. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

ARQT - Latest Insights

ARQT
Nov 05, 2026, 11:52 AM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $26.96
Real-time Price: $27.86 info
Change: +$0.900 (+3%) info
Market Cap: $3.436B info
ARQT
Nov 04, 2026, 4:04 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $31.25
Real-time Price: $27.86 info
Change: -$3.39 (-11%) info
Market Cap: $3.436B info
ARQT
Nov 04, 2026, 4:02 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $32.30
Real-time Price: $27.86 info
Change: -$4.44 (-14%) info
Market Cap: $3.436B info
ARQT
Nov 04, 2026, 4:00 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $34.23
Real-time Price: $27.86 info
Change: -$6.37 (-19%) info
Market Cap: $3.436B info
ARQT
Aug 20, 2026, 1:38 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $24.92
Real-time Price: $27.86 info
Change: +$2.94 (+12%) info
Market Cap: $3.436B info